New therapy aims to tame deadly sepsis
NCT ID NCT07388628
Summary
This study is collecting real-world information on a treatment called ARTICE for people with severe sepsis or septic shock in the ICU. It aims to see how well the treatment works by tracking organ function, survival rates, and hospital stay length. The goal is to better understand which patients might benefit most from this therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin
RECRUITINGMagdeburg, 39130, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.